JP2014209129A5 - - Google Patents

Download PDF

Info

Publication number
JP2014209129A5
JP2014209129A5 JP2014145082A JP2014145082A JP2014209129A5 JP 2014209129 A5 JP2014209129 A5 JP 2014209129A5 JP 2014145082 A JP2014145082 A JP 2014145082A JP 2014145082 A JP2014145082 A JP 2014145082A JP 2014209129 A5 JP2014209129 A5 JP 2014209129A5
Authority
JP
Japan
Prior art keywords
test substance
loaded
animal
inoculated
excluding humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014145082A
Other languages
English (en)
Japanese (ja)
Other versions
JP5836444B2 (ja
JP2014209129A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014145082A priority Critical patent/JP5836444B2/ja
Priority claimed from JP2014145082A external-priority patent/JP5836444B2/ja
Publication of JP2014209129A publication Critical patent/JP2014209129A/ja
Publication of JP2014209129A5 publication Critical patent/JP2014209129A5/ja
Application granted granted Critical
Publication of JP5836444B2 publication Critical patent/JP5836444B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014145082A 2006-09-06 2014-07-15 被検物質の評価方法 Expired - Fee Related JP5836444B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014145082A JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006240924 2006-09-06
JP2006240924 2006-09-06
JP2014145082A JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013048403A Division JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法

Publications (3)

Publication Number Publication Date
JP2014209129A JP2014209129A (ja) 2014-11-06
JP2014209129A5 true JP2014209129A5 (https=) 2015-03-26
JP5836444B2 JP5836444B2 (ja) 2015-12-24

Family

ID=39157262

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008533183A Withdrawn JPWO2008029836A1 (ja) 2006-09-06 2007-09-05 研究、判定又は評価法
JP2013048403A Expired - Fee Related JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法
JP2014145082A Expired - Fee Related JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008533183A Withdrawn JPWO2008029836A1 (ja) 2006-09-06 2007-09-05 研究、判定又は評価法
JP2013048403A Expired - Fee Related JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法

Country Status (3)

Country Link
US (1) US7923254B2 (https=)
JP (3) JPWO2008029836A1 (https=)
WO (1) WO2008029836A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101528947A (zh) * 2006-09-06 2009-09-09 日本脏器制药株式会社 通过基因表达分析进行研究、判定或评价的方法
JP5229789B2 (ja) * 2007-02-27 2013-07-03 プリマハム株式会社 新規ストレスバイオマーカー及びその用途
JP5513802B2 (ja) * 2009-08-04 2014-06-04 ホーユー株式会社 等電点電気泳動用ゲル及び等電点電気泳動方法
US9447466B2 (en) 2010-06-25 2016-09-20 Nippon Zoki Pharmaceutical Co., Ltd. Method for determination or evaluation of test substance
DE102014204514A1 (de) * 2014-03-12 2015-09-17 NH DyeAGNOSTICS GmbH Verfahren und Kit zum Überwachen der Probenvorbereitung, von chemischen Markierungsreaktionen und von Antikörperreaktionen
JP6169807B2 (ja) * 2015-05-29 2017-07-26 日本臓器製薬株式会社 多能性幹細胞遊走促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
TWI342778B (en) * 2002-10-31 2011-06-01 Nippon Zoki Pharmaceutical Co Therapeutic agent for fibromyalgia
KR101346073B1 (ko) 2005-03-07 2013-12-31 니폰 조키 세야쿠 가부시키가이샤 연구, 판정 또는 평가 방법

Similar Documents

Publication Publication Date Title
Bondi et al. Found in translation: understanding the biology and behavior of experimental traumatic brain injury
JP2014209129A5 (https=)
Xi et al. Progress in translational research on intracerebral hemorrhage: is there an end in sight?
Pasciuto et al. Autism spectrum disorders: translating human deficits into mouse behavior
Matsumoto et al. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects
EA201790398A1 (ru) Способы лечения заболевания печени
CY1120390T1 (el) Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων
CL2019000261A1 (es) Polipéptidos modificados y usos de los mismos.
JP2017526437A5 (ja) 遠隔虚血コンディショニングを行うシステムが組み込まれている医療装置、医療装置を動作させる方法、コンピュータ可読記憶媒体、台、及び自動体外式除細動器
EP3043875A4 (en) Method to determine body's physiological response to physical exercise for assessing readiness and to provide feedback, and system for implementing the method
SA517380842B1 (ar) بروتينات دمج لمستقبل إنترليوكين-2/إنترليوكين-2 ألفا وطرق الاستخدام
CL2016002683A1 (es) Proteínas agonistas de los receptores de trail de cadena simple
CY1125938T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες του ενδομητριου
BR112015026122A2 (pt) métodos para usar interleucina-10 para tratar doenças e desordens
BR112018074869A2 (pt) anticorpos antagonistas que ligam t ao tgfb1, tgfb2 e ao tgfb3 humanos e seu uso para o tratamento de fibrose pulmonar
WO2014120975A8 (en) Antibody-mediated immunocontraception
BR112016004324A2 (pt) anticorpos
MX378857B (es) Celulas huespedes modificadas y usos de las mismas.
IL290817A (en) Methods for production of human recombinant arginase 1 and uses thereof
PH12017502099B1 (en) Methods for diagnosing and assessing treatment for cushing's syndrome
BR112016004450A2 (pt) métodos para tratar uma doença, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir desenvolvimento da reincidência e/ou resistência de uma doença, para aumentar a sensibilidade a um inibidor, para estender o período de sensibilidade a um inibidor e para estender a duração de resposta a um inibidor
Tepper et al. Methods, measurements, and interpretation of animal lung function in health and disease
BR112015028986A2 (pt) métodos para produzir partículas compreendendo proteínas terapêuticas
Aslam et al. The effect of vitamin c addition in andromed® dilution on procentage of motility and spermatozoa intact plasma membrane of aceh bull after freezing
Sierra Raquel Ormella, I live with Birds: Critical Response